Johnson & Johnson Vision Showcases Latest Clinical Data and Eye Care Solutions at ESCRS 2019 Annual Meeting
- Johnson & Johnson Vision to launch in Europe newest intraocular lens (IOL) TECNIS Synergy™ IOL and preloaded SmartLOAD™ Delivery Technology cartridge designed to optimize monofocal IOL delivery with reusable UNFOLDER VITAN™ inserter
- The company will host a series of educational and interactive sessions to offer attendees the opportunity to share, discuss and learn from leading experts in the field of ophthalmology
Paris, France (September 11, 2019) – Johnson & Johnson Vision,ǂ a broad-based global leader in vision, will highlight key clinical data and the latest solutions in its growing portfolio of innovative products designed to improve vision care across generations at the upcoming European Society of Cataract and Refractive Surgeons (ESCRS) 2019 Annual Meeting in Paris, France, September 14-18.
“As a global leader in eye health, Johnson & Johnson Vision is continuing to support eye care professionals with a new portfolio of products from innovative intraocular lenses that are changing the trajectory of eye health to next-generation IOL insertion systems that are enhancing the surgical experience,” said Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision.†” At ESCRS this year, in addition to unveiling our newest intraocular lens, TECNIS Synergy™ IOL, we are hosting a number of educational events and presenting a range of new innovations and data findings. We are also putting community and sustainability at the heart of our ESCRS activities. We will be hosting an interactive space for healthcare professionals – the J&J Vision Lighthouse – as well as creating our first ever zero-waste booth.”
Cataract surgery is the most common surgery performed around the world.1 At ESCRS 2019, Johnson & Johnson Vision will be showcasing innovations designed to address the needs of those living with cataracts, which cause vision to deteroriate over time, if left untreated.
The company will offer a series of educational sessions for the ophthamology community about the latest advancements in surgical vision, as well as announce the upcoming availability of its new TECNIS Synergy™ IOL and preloaded SmartLOAD™ Delivery Technology cartridge designed to optimize monofocal IOL delivery with reusable UNFOLDER VITAN™ inserter.
Furthermore, Johnson & Johnson Vision will share insights around its latest TearScience LipiScan™ Dynamic Meibomian Imager and LipiFlow® Thermal Pulsation suite of products and expanded availability across Europe.
Key Presentations include:
TECNIS Eyhance™ IOL in cataract surgery: the first experiences, A.Barisic
- Poster Session: Pseudophakic IOLs: Monofocal
- Poster Session: Pseudophakic IOLs: Enlarged-Depth-of-Focus Canovas
- Moderated Poster Session: Finding the Right Pseudophakic Presbyopia Treatment
- Venue: Poster Village: Pod 2
Clinical investigation of a new preloaded insertion system used during cataract surgery, B.Cronin
- Session Title: Cataract Surgery Equipment
- Session Date/Time: Monday 16/09/2019 | 08:30-10:30 (Paper Time: 08:42)
- Venue: Free Paper Forum: Podium 3
First real-world experience with a new monofocal lens design, W.Goslings
- Session Title: Monofocal IOLs: New Biomaterials & Visual Performance
- Session Date/Time: Tuesday 17/09/2019 | 16:30-18:00 (Paper Time: 17:00)
- Venue: Free Paper Forum: Podium 2
New monofocal IOLs and the challenge of the intermediate distance, R.Mencucci
- Session Title: Monofocal IOLs: New Biomaterials & Visual Performance
- Session Date/Time: Tuesday 17/09/2019 | 16:30-18:00 (Paper Time: 17:12)
- Venue: Free Paper Forum: Podium 2
- Session Title: New IOL Optic Design
- Session Date/Time: Tuesday 17/09/2019 | 16:30-18:00 (Paper Time: 16:30)
- Venue: Free Paper Forum: Podium 1
- Session Title: Quality of Vision Evaluation
- Session Date/Time: Tuesday 17/09/2019 | 16:30-18:00 (Paper Time: 16:48)
- Venue: Free Paper Forum: Podium 4
J&J Booth:
Johnson & Johnson Vision’s exhibit booth will host a variety of interactive experiences, as well as offering attendees the opportunity to speak firsthand with a range of KOLs and experts in the areas of cataract, ocular surface health and refractive surgery.
In addition, the booth will be committed to zero waste and off setting any carbon emissions. As well as reducing paper through the use of digital technology and eliminating the use of plastic, delegates will be offered refreshments in seed-containing, bio-degradable cups which can subsequently be planted to grow a tree.
Visit the booth to find out more – Pavilion 7, Floor 7.2 Booth #E112.
J&J Vision Lighthouse:
Johnson & Johnson Vision have again collaborated with ESCRS to create the “J&J Vision Lighthouse”. This unique space will host a series of events, showcase J&J’s innovative product portfolio and provide a venue for networking and knowledge sharing.
Terminal 7, Floor 4, JJV Lighthouse
J&J Vision’s Activities at ESCRS:
Throughout the meeting, the company will host a series of educational and interactive sessions aimed at sparking conversation and providing an opportunity to share, discuss and learn from leading experts in the field of ophthalmology. These include:
Meet the Experts – Peer-to-peer discussion with acknowledged experts on various areas of cataract, ocular surface health & refractive surgery.
- J&J Booth / Saturday, September 14 - Monday, September 16, 2019
EuroTimes Satellite Education Program: Synergizing the best of two worlds in presbyopia-correcting IOL technologies
- FPF (Pavilion 7, Floor 3, Paris Expo, Porte de Versailles) / Saturday, September 14, 2019 • 1:00 - 2:00 p.m
EuroTimes Satellite Symposium: Challenging the Standard for Monofocal IOLs
- SOUTH 2 (Pavilion 7, Floor 3, Paris Expo, Porte de Versailles) / Sunday, September 15, 2019 • 1:00 - 2:00 p.m.
EuroTimes Satellite Symposium: Ocular Surface Disease Diagnosis and Management: Special focus on the lipid layer
- NORTH 4 (Pavilion 7, Floor 3, Paris Expo, Porte de Versailles) / Saturday, September 14, 2019 • 1:00 - 2:00 p.m.
EuroTimes Satellite Symposium: Presbyopia and Toric IOL Correction: Keys to success with multifocal and EDOF IOLs
- NORTH 4 (Pavilion 7, Floor 3, Paris Expo, Porte de Versailles) / Monday, September 16, 2019 • 1:00 - 2:30 p.m.
About Cataracts and Presbyopia:
Cataracts are the leading cause of blindness globally.2 More than 90 percent of people develop cataracts by age 65.3 Left untreated, cataracts cause vision to deteriorate over time. Cataract surgery is the most common surgery performed around the world,1 including more than 4 million times in the EU in 2016.4
Many people who have cataracts experience other problems with their vision, such as presbyopia. Cataract surgery is a unique opportunity to address presbyopia without an additional procedure. Presbyopia is a progressive eye condition, which makes it difficult to focus on close objects and usually becomes noticeable around 40 years of age.5
About Johnson & Johnson Vision:
At Johnson & Johnson Vision, part of Johnson & Johnson Medical Devices Companies,* we have a bold ambition: to change the trajectory of eye health around the world. Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts and dry eye. In communities with greatest need, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better and live better. Visit us at www.jjvision.com. Follow @JNJVision on Twitter and Johnson & Johnson Vision on LinkedIn.
About Johnson & Johnson Medical Devices Companies:
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.
For further information, contact:
Sally Hetherington
Leader, EMEA Communications
Johnson & Johnson Vision
T: +44 1344 324635
M: +44 7770 337800
SHether1@its.jnj.com
Amy Murray
FleishmanHillard Fishburn
T: +44 20 861 82981
M: +44 7540 002205
amy.murray@fhflondon.co.uk
ǂ Johnson & Johnson Surgical Vision, Inc.
† Employed by Johnson & Johnson Surgical Vision, Inc.
* The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, vision and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment.
TECNIS Synergy™ IOL and TECNIS Synergy™ OptiBlue™ IOL are not approved worldwide and are specifically not available for commercial distribution in the U.S.
References:
1Trikha S, et al. The Journey to Femtosecond Laser-Assisted Cataract Surgery: New Beginnings or False Dawn? Eye 2013;27:461-473. REF2015OTH0014.
2World Health Organization - Priority Eye Diseases. REF2016OTH0004.
3University of Michigan Kellogg Eye Center website. http://www.kellogg.umich.edu/patientcare/conditions/cataract.html. Accessed October 28, 2017. REF2016OTH0327.
4Eurostat - Surgical operations and procedures statistics. https://ec.europa.eu/eurostat/statistics-explained/index.php/Surgical_operations_and_procedures_statistics#In-patient_procedures:_cataract_surgery. Accessed December 18, 2018. REF2018CT4377.
5American Optometric Association. Presbyopia. American Optometric Association (AOA) Web site. https://www.aoa.org/patients-and-public/eye-and-vision-problems/glossary-of-eye-and-vision-conditions/presbyopia. Accessed July 3, 2019. REF2019CT4316.
For healthcare professionals only. Please read the Directions for Use for Important Safety Information and consult our specialists if you have any questions.
© Johnson & Johnson Surgical Vision, Inc. 2019.
PP2019CT4803
